ImpediMed

Call Directions Website

ImpediMed The world leader in the development and distribution of medical devices utilizing bioimpedance spectroscopy (BIS).

We're at JADPRO Live in Minneapolis, Booth 215.Advanced practitioners are central to survivorship: they're often the one...
10/16/2026

We're at JADPRO Live in Minneapolis, Booth 215.

Advanced practitioners are central to survivorship: they're often the ones tracking how a patient is doing long after active treatment ends. Objective, whole-body data helps make those follow-ups sharper.

Stop by Booth 215 to see how the SOZO® Digital Health Platform supports lymphedema surveillance and body composition monitoring across survivorship.

📍 Minneapolis, MN · Booth 215

Learn more: https://ow.ly/nXAW50ZYyru

By the time lymphedema is visible, it's already harder to manage.Up to 58% of cancer patients are at risk for limb lymph...
10/13/2026

By the time lymphedema is visible, it's already harder to manage.

Up to 58% of cancer patients are at risk for limb lymphedema, and for breast cancer patients that risk can climb higher depending on treatment. The window that matters most is the one before symptoms appear, when the condition is still reversible.

That's the case for prospective surveillance. The SOZO® Digital Health Platform with L-Dex® is the only FDA-cleared bioimpedance spectroscopy (BIS) solution for the clinical assessment of lymphedema, measuring subclinical fluid changes so clinicians can intervene early. In PREVENT, the largest randomized controlled trial for lymphedema prevention in breast cancer patients, 92% of patients whose subclinical lymphedema was caught early with BIS and treated did not progress to chronic lymphedema.

🔗 See how the Lymphedema Prevention Program works: https://ow.ly/cQCM50ZX162

Breast Cancer Awareness Month continues, and we're proud to support the organizations that are making a difference.Our t...
10/12/2026

Breast Cancer Awareness Month continues, and we're proud to support the organizations that are making a difference.

Our team was at the I Pink I Can Pink Party in New Jersey, celebrating patients, survivors, and families.

Community and clinical progress, side by side. Grateful to be part of both.

This Breast Cancer Awareness Month, we're focused on what comes after diagnosis and treatment.Some of the changes that m...
10/08/2026

This Breast Cancer Awareness Month, we're focused on what comes after diagnosis and treatment.

Some of the changes that matter most in survivorship begin before a patient reports a symptom. Fluid shifts that can signal lymphedema. Losses in muscle mass the scale won't show.

The SOZO® Digital Health Platform gives care teams objective, real-time insight into how each patient's body is changing, from diagnosis through survivorship. With L-Dex® for lymphedema surveillance and BodyComp™ Analysis for lean and fat mass, care can be tailored to how the body is genuinely responding, and trends can be identified earlier.

🔗 Explore survivorship care: https://ow.ly/kL5S50ZSoQL

Tomorrow: prospective surveillance and the new 2027 NAPBC standards.Join Nicole L. Stout, DPT, CLT-LANA, FAPTA on Wednes...
10/06/2026

Tomorrow: prospective surveillance and the new 2027 NAPBC standards.

Join Nicole L. Stout, DPT, CLT-LANA, FAPTA on Wednesday, October 7 at 6pm ET for a free webinar on how one surveillance model can align your breast cancer center to three of the 2027 NAPBC standards. There is still time to register.

🔗 Save your spot: https://ow.ly/grHg50ZSoEo

Breast Cancer Awareness Month started with our teams showing up across the country.This weekend we were at the Passport ...
10/05/2026

Breast Cancer Awareness Month started with our teams showing up across the country.

This weekend we were at the Passport to Survivorship Expo with the Gloria Gemma Foundation in Providence, the All Things Pink Out 5K in Phoenix, and the LBBC Survivorship Conference in Philadelphia. Three very different rooms, one shared focus: life after breast cancer, and the care that supports it.

Thank you to everyone who stopped by to talk survivorship, early lymphedema detection, and whole-body monitoring with the SOZO® Digital Health Platform.

📍 Providence, RI · Phoenix, AZ · Philadelphia, PA

https://ow.ly/gfAU50ZUwIj

New NAPBC standards arrive in 2027. One care model can help you meet three of these standards.Join us Wednesday, October...
10/01/2026

New NAPBC standards arrive in 2027. One care model can help you meet three of these standards.

Join us Wednesday, October 7 at 6pm ET for a free webinar with Nicole L. Stout, DPT, CLT-LANA, FAPTA, Senior Director of Survivorship and Wellness at the American Cancer Society.

Dr. Stout will show how a prospective surveillance model, using baseline and interval measurement across the care continuum, can align a breast cancer center to the 2027 NAPBC Standards for Lymphedema Assessment (5.8), Return to Wellness (5.15), and Surveillance for long-term and late effects (5.16). You will leave with the evidence behind prospective surveillance, the clinical time points that matter most, and implementation strategies from real programs.

The SOZO® Digital Health Platform with L-Dex® supports the lymphedema surveillance piece of that model.

🔗 Register: https://ow.ly/IQgC50ZSouk

Today is World Heart Day.In heart failure, fluid often shifts before the scale moves. That change is hard to see without...
09/29/2026

Today is World Heart Day.

In heart failure, fluid often shifts before the scale moves. That change is hard to see without objective measurement.

The SOZO® Digital Health Platform with HF-Dex® supports fluid status monitoring in heart failure, giving care teams an objective read in one rapid scan.

🔗 Learn more: https://ow.ly/FTKv50ZOvrf

We're at the TME Summit in New Orleans.Survivorship care keeps moving toward earlier, more objective monitoring, from ly...
09/25/2026

We're at the TME Summit in New Orleans.

Survivorship care keeps moving toward earlier, more objective monitoring, from lymphedema surveillance to body composition supporting exercise oncology and return to wellness. The SOZO® Digital Health Platform brings that data together in one rapid scan.

Stop by to talk with our team.

📍 Booth 12, New Orleans, LA

🔗 Learn more: https://ow.ly/CzwP50ZRCIT

The GLP-1 era has reshaped the weight-loss conversation. A recent Cancer Fitness commentary argues it should reshape ano...
09/23/2026

The GLP-1 era has reshaped the weight-loss conversation. A recent Cancer Fitness commentary argues it should reshape another one too: for people affected by cancer, what matters is not how much weight comes off, but how much muscle stays on.

Rapid weight loss can pull from lean muscle, not just fat. In oncology, lower muscle mass has been linked to greater treatment toxicity, more fatigue, and harder recoveries. Weight and BMI alone can hide that picture.

Objective body composition data can bring it into focus. The SOZO® Digital Health Platform uses bioimpedance spectroscopy to measure muscle mass indices that help clinicians distinguish muscle from fat and assess patients at risk of sarcopenia. With SOZO's recent FDA clearance to aid clinicians in assessing patients at risk of sarcopenia, there's another objective way to look past the scale and track muscle health over time.

🔗 Read the article: https://ow.ly/GvcA50ZOvB7

Address

Carlsbad, CA
92008

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Telephone

+17605852100

Website

Alerts

Be the first to know and let us send you an email when ImpediMed posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category